Hinge Health (NYSE:HNGE) Sees Large Volume Increase – Should You Buy?

Hinge Health Inc. (NYSE:HNGE) saw an uptick in trading volume on Tuesday . 2,774,755 shares were traded during mid-day trading, an increase of 156% from the previous session’s volume of 1,083,227 shares.The stock last traded at $40.3940 and had previously closed at $40.84.

Analysts Set New Price Targets

Several research firms have recently issued reports on HNGE. Bank of America raised their price objective on Hinge Health from $42.00 to $64.00 and gave the stock a “buy” rating in a report on Wednesday, August 6th. Stifel Nicolaus upped their price objective on shares of Hinge Health from $63.00 to $66.00 and gave the company a “buy” rating in a research note on Thursday, September 11th. Evercore ISI raised their target price on shares of Hinge Health from $60.00 to $65.00 and gave the stock an “outperform” rating in a research report on Wednesday, October 8th. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Hinge Health in a research report on Wednesday, October 8th. Finally, Barclays lifted their price target on shares of Hinge Health from $62.00 to $65.00 and gave the company an “overweight” rating in a report on Wednesday, November 5th. One analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $59.93.

Hinge Health Trading Up 2.8%

The business has a 50-day simple moving average of $49.92.

Hinge Health (NYSE:HNGE) last issued its quarterly earnings data on Tuesday, November 4th. The company reported ($0.02) EPS for the quarter, topping analysts’ consensus estimates of ($0.20) by $0.18. The company had revenue of $154.21 million for the quarter, compared to analyst estimates of $142.44 million. The business’s revenue was up 53.3% compared to the same quarter last year. Hinge Health has set its FY 2025 guidance at EPS. Q4 2025 guidance at EPS.

Hinge Health announced that its board has initiated a stock buyback program on Wednesday, November 12th that permits the company to buyback $250.00 million in outstanding shares. This buyback authorization permits the company to buy up to 7.2% of its shares through open market purchases. Shares buyback programs are often a sign that the company’s board of directors believes its stock is undervalued.

Insider Buying and Selling

In other Hinge Health news, Director Kristina M. Leslie sold 3,813 shares of Hinge Health stock in a transaction that occurred on Wednesday, November 19th. The stock was sold at an average price of $43.60, for a total transaction of $166,246.80. Following the sale, the director directly owned 29,000 shares in the company, valued at $1,264,400. The trade was a 11.62% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, major shareholder Bessemer Venture Partners X. L. sold 725,000 shares of the company’s stock in a transaction that occurred on Tuesday, November 18th. The shares were sold at an average price of $40.05, for a total value of $29,036,250.00. Following the completion of the transaction, the insider directly owned 3,383,707 shares in the company, valued at approximately $135,517,465.35. The trade was a 17.65% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last 90 days, insiders have sold 731,000 shares of company stock valued at $29,290,983.

Institutional Investors Weigh In On Hinge Health

Hedge funds and other institutional investors have recently modified their holdings of the stock. Mirae Asset Global Investments Co. Ltd. bought a new position in shares of Hinge Health during the third quarter worth about $37,000. Montag A & Associates Inc. bought a new position in Hinge Health during the 2nd quarter worth approximately $41,000. SBI Securities Co. Ltd. acquired a new position in shares of Hinge Health in the 2nd quarter worth approximately $48,000. Aster Capital Management DIFC Ltd bought a new stake in shares of Hinge Health in the 3rd quarter valued at approximately $49,000. Finally, Jones Financial Companies Lllp lifted its stake in Hinge Health by 348.0% during the third quarter. Jones Financial Companies Lllp now owns 1,120 shares of the company’s stock worth $54,000 after purchasing an additional 870 shares during the last quarter.

Hinge Health Company Profile

Our vision is to build a new health system that transforms outcomes, experience and costs by using technology to scale and automate the delivery of care. Hinge Health leverages software, including AI, to largely automate care for joint and muscle health, delivering an outstanding member experience, improved member outcomes, and cost reductions for our clients.